🔎 Trials Near Me

Beranda › Limfoma Hodgkin › Tennessee

Uji klinis Limfoma Hodgkin di Tennessee

8 studi untuk Limfoma Hodgkin mencari peserta di lokasi di Tennessee.

Kota di Tennessee

Teks studi resmi (Bahasa Inggris)

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

  • St. Jude Children's Research Hospital, Memphis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06421987

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

  • St. Jude Children's Research Hospital, Memphis
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07514819

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • Tennessee Oncology, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT06150664

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • St. Jude Childrens Research Hospital, Memphis
  • Vanderbilt University, Nashville
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Familial Investigations of Childhood Cancer Predisposition

  • St. Jude Children's Research Hospital, Memphis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT03050268

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

  • St. Jude Children's Research Hospital, Memphis
Menerima peserta
Usia 10 hingga 25 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT07222345

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

  • St. Jude Children's Research Hospital, Memphis
Menerima pesertaStudi observasional
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06098430

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • St. Jude Children's Research Hospital, Memphis
Menerima pesertaFase 1
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.